M/04/006 – Abbott Laboratories/TheraSense

Page Attachments


Transaction details

Proposal whereby Abbott Laboratories (“Abbott”) would acquire all the issued shares of TheraSense, Inc.

Notification date Decision date
Monday January 26, 2004 Thursday, February 26, 2004
Parties Involved Business activities
Abbott Laboratories

TheraSense develops, manufactures and sells glucose monitoring systems designed to reduce the pain of testing for people with diabetes.

Economic sector Media merger
Health Care No
Submissions from third parties due by:
Phase 1 Phase 2
Current status: Completed
Preliminary investigation (Phase 1)
Authorised Officer Assigned Contact Details


Media enquiries: MKC Communications: 01 7038600

Return to Merger Notifications

Haven’t found what you’re looking for?